Abbott Laboratories buy Raymond James
Start price
25.01.24
/
50%
€102.62
Target price
25.01.25
€116.71
Performance (%)
-4.76%
Price
10.05.24
€97.22
Summary
This prediction is currently active. With a performance of -4.76%, the BUY prediction for Abbott Laboratories by Raymond_James is down slightly. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 25.01.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -1.179% | -1.179% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Raymond_James for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Raymond James from $124.00 to $127.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Raymond_James for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.30
03.01.24
03.01.24
€113.61
03.01.25
03.01.25
-2.06%
10.05.24
10.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€104.02
19.10.24
19.10.24
10.50%
10.05.24
10.05.24